(February 6, 2019, 8:45 AM EST) -- PHILADELPHIA — A Pennsylvania-based compounding pharmacy on Feb. 4 entered into an agreement in Pennsylvania federal court with the federal government in which it agreed to pay $1.7 million to resolve allegations in a suit brought by a former employee under the qui tam provision of the False Claims Act in which she claimed that the company submitted fraudulent bills to Medicare and Medicaid for its drug Proplete (United States et al. ex rel. Jean Brasher v. Pentec Health, Inc., No. 13-cv-05745, E.D. Pa.)....